CVE-2009-1934

Description

Cross-site scripting (XSS) vulnerability in the Reverse Proxy Plug-in in Sun Java System Web Server 6.1 before SP11 allows remote attackers to inject arbitrary web script or HTML via the query string in situations that result in a 502 Gateway error.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.60%
Vendor Advisory sun.com Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://sunsolve.sun.com/search/document.do?assetkey=1-66-259588-1 patch vendor advisory
http://secunia.com/advisories/35338 third party advisory vendor advisory
http://www.securityfocus.com/bid/35204 vdb entry
http://osvdb.org/54872 vdb entry
http://sunsolve.sun.com/search/document.do?assetkey=1-21-116648-23-1 patch
http://www.vupen.com/english/advisories/2009/1500 vdb entry
http://www.securitytracker.com/id?1022334 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/50951 vdb entry
http://support.avaya.com/elmodocs2/security/ASA-2009-211.htm

Frequently Asked Questions

What is the severity of CVE-2009-1934?
CVE-2009-1934 has been scored as a medium severity vulnerability.
How to fix CVE-2009-1934?
To fix CVE-2009-1934, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2009-1934 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2009-1934 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.